IN HB1225 | 2021 | Regular Session
Status
Completed Legislative Action
Spectrum: Slight Partisan Bill (Republican 6-3)
Status: Passed on April 29 2021 - 100% progression
Action: 2021-04-29 - Public Law 181
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Slight Partisan Bill (Republican 6-3)
Status: Passed on April 29 2021 - 100% progression
Action: 2021-04-29 - Public Law 181
Text: Latest bill text (Enrolled) [PDF]
Summary
Opioid treatment programs. Requires an opioid treatment program to obtain prior authorization from the division of mental health and addiction (division) for patients receiving more than 14 days of opioid treatment medication from an opioid treatment program unless otherwise prescribed by the division. Allows the state opioid treatment authority (authority) to: (1) take certain remedial actions; and (2) impose a civil penalty of up to $10,000; in response to certain violations concerning the operation of an opioid treatment program. Specifies that the authority may issue a civil penalty for each violation found by the authority. Requires the division to report certain findings to the general assembly not later than April 1 of each year. Requires certain information to be provided to the division for the purpose of completing specified reporting requirements.
Title
Opioid treatment programs.
Sponsors
Roll Calls
2021-04-13 - Senate - Senate - Third reading (Y: 31 N: 17 NV: 1 Abs: 1) [PASS]
2021-03-10 - Senate - Senate - Committee Vote (Y: 11 N: 0 NV: 0 Abs: 0) [PASS]
2021-02-01 - House - House - Third reading (Y: 96 N: 1 NV: 1 Abs: 2) [PASS]
2021-01-26 - House - House - Committee Vote (Y: 13 N: 0 NV: 0 Abs: 0) [PASS]
2021-03-10 - Senate - Senate - Committee Vote (Y: 11 N: 0 NV: 0 Abs: 0) [PASS]
2021-02-01 - House - House - Third reading (Y: 96 N: 1 NV: 1 Abs: 2) [PASS]
2021-01-26 - House - House - Committee Vote (Y: 13 N: 0 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2021-04-29 | House | Public Law 181 |
2021-04-29 | House | Signed by the Governor |
2021-04-28 | Senate | Signed by the President of the Senate |
2021-04-23 | Senate | Signed by the President Pro Tempore |
2021-04-16 | House | Signed by the Speaker |
2021-04-14 | Senate | Returned to the House without amendments |
2021-04-13 | Senate | Third reading: passed; Roll Call 419: yeas 31, nays 17 |
2021-04-12 | Senate | Reread second time: ordered engrossed |
2021-03-18 | Senate | Placed back on second reading |
2021-03-18 | Senate | Senator Randolph added as cosponsor |
2021-03-15 | Senate | Second reading: ordered engrossed |
2021-03-11 | Senate | Senator Yoder added as cosponsor |
2021-03-11 | Senate | Senator Becker added as third sponsor |
2021-03-11 | Senate | Committee report: do pass, adopted |
2021-03-01 | Senate | Senator Charbonneau added as second sponsor |
2021-02-18 | Senate | First reading: referred to Committee on Health and Provider Services |
2021-02-02 | House | Referred to the Senate |
2021-02-01 | House | Senate sponsor: Senator Crider |
2021-02-01 | House | Third reading: passed; Roll Call 25: yeas 96, nays 1 |
2021-01-28 | House | Representative Shackleford added as coauthor |
2021-01-28 | House | Representative Davisson added as coauthor |
2021-01-28 | House | Second reading: ordered engrossed |
2021-01-26 | House | Committee report: do pass, adopted |
2021-01-14 | House | First reading: referred to Committee on Public Health |
2021-01-14 | House | Coauthored by Representative Clere |
2021-01-14 | House | Authored by Representative Vermilion |